ES2151652T3
(es)
*
|
1995-02-02 |
2001-01-01 |
Smithkline Beecham Plc |
Derivados de indol como antagonistas del receptor 5ht.
|
GB9517559D0
(en)
*
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
GB9607219D0
(en)
*
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
GB9612883D0
(en)
*
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9612885D0
(en)
*
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
GB9710523D0
(en)
*
|
1997-05-23 |
1997-07-16 |
Smithkline Beecham Plc |
Novel compounds
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
US6022884A
(en)
*
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
WO1999043650A2
(en)
*
|
1998-02-25 |
1999-09-02 |
Smithkline Beecham Plc |
Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
|
CA2325559A1
(en)
*
|
1998-04-14 |
1999-10-21 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6140509A
(en)
*
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6150393A
(en)
*
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
US7141581B2
(en)
|
1999-07-02 |
2006-11-28 |
Agouron Pharmaceuticals, Inc. |
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
CA2378243C
(en)
*
|
1999-08-04 |
2012-05-15 |
Icagen, Inc. |
Methods for treating or preventing pain and anxiety
|
AUPQ319899A0
(en)
|
1999-10-01 |
1999-10-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
AU2001241128A1
(en)
*
|
2000-03-14 |
2001-09-24 |
Fujisawa Pharmaceutical Co. Ltd. |
Novel amide compounds
|
US6448293B1
(en)
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
FR2807754A1
(fr)
*
|
2000-04-13 |
2001-10-19 |
Adir |
Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JP2004501083A
(ja)
|
2000-04-18 |
2004-01-15 |
アゴーロン・ファーマシューティカルズ・インコーポレイテッド |
プロテインキナーゼを阻害するためのピラゾール
|
GB0019950D0
(en)
*
|
2000-08-12 |
2000-09-27 |
Smithkline Beecham Plc |
Compounds
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
US6610747B2
(en)
|
2000-08-31 |
2003-08-26 |
Pfizer Inc. |
Phenoxybenzylamine derivatives as SSRIs
|
US6630504B2
(en)
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
JP4160295B2
(ja)
*
|
2000-12-08 |
2008-10-01 |
武田薬品工業株式会社 |
3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
|
US7067539B2
(en)
|
2001-02-08 |
2006-06-27 |
Schering Corporation |
Cannabinoid receptor ligands
|
US7507767B2
(en)
|
2001-02-08 |
2009-03-24 |
Schering Corporation |
Cannabinoid receptor ligands
|
GB2380190A
(en)
*
|
2001-08-28 |
2003-04-02 |
Bayer Ag |
Antiinflammatory heterocyclic sulphones
|
AU2002362426B2
(en)
|
2001-09-29 |
2008-09-11 |
Lg Electronics Inc. |
Method for transferring and/or receiving data in communication system and apparatus thereof
|
US7071213B2
(en)
|
2001-11-14 |
2006-07-04 |
Schering Corporation |
Cannabinoid receptor ligands
|
GB0200283D0
(en)
*
|
2002-01-08 |
2002-02-20 |
Smithkline Beecham Plc |
Compounds
|
CA2480880C
(en)
|
2002-04-08 |
2011-03-22 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
CA2480800C
(en)
|
2002-04-08 |
2008-09-23 |
Mark T. Bilodeau |
Inhibitors of akt activity
|
WO2004000807A1
(en)
|
2002-06-19 |
2003-12-31 |
Schering Corporation |
Cannabinoid receptor agonists
|
WO2004004720A1
(en)
*
|
2002-07-03 |
2004-01-15 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
JP4667867B2
(ja)
|
2002-08-02 |
2011-04-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
置換フロ[2,3−b]ピリジン誘導体
|
NZ537980A
(en)
*
|
2002-08-23 |
2007-08-31 |
Rigel Pharmaceuticals Inc |
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
EP1558586B1
(en)
|
2002-10-30 |
2011-03-30 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
US20060194825A1
(en)
*
|
2002-12-20 |
2006-08-31 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
WO2004058683A2
(en)
*
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
AU2003297441A1
(en)
*
|
2002-12-24 |
2004-07-22 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
US7638530B2
(en)
|
2003-04-24 |
2009-12-29 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
EP1631546A1
(en)
*
|
2003-04-25 |
2006-03-08 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
WO2005002673A1
(en)
*
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
PT1558582E
(pt)
|
2003-07-22 |
2006-05-31 |
Arena Pharm Inc |
Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo
|
WO2005037199A2
(en)
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
ATE548353T1
(de)
*
|
2004-03-23 |
2012-03-15 |
Arena Pharm Inc |
Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
KR20140048343A
(ko)
*
|
2004-09-02 |
2014-04-23 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
SA05260357B1
(ar)
*
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
WO2006060762A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
WO2006078610A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
WO2007026920A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
WO2007054257A2
(en)
|
2005-11-08 |
2007-05-18 |
Laboratorios Del Dr. Esteve, S.A. |
Indene derivatives, their preparation and use as medicaments
|
CA2646081C
(en)
|
2006-05-18 |
2017-06-27 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
USRE45337E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
CA2654898A1
(en)
*
|
2006-07-07 |
2008-10-01 |
Boehringer Ingelheim International Gmbh |
New chemical compounds
|
EP1884515A1
(en)
|
2006-07-31 |
2008-02-06 |
Laboratorios del Dr. Esteve S.A. |
Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
|
TWI415845B
(zh)
*
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
WO2008058341A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Cytopia Research Pty Ltd |
Inhibitors of kinase activity
|
US9187485B2
(en)
|
2007-02-02 |
2015-11-17 |
Baylor College Of Medicine |
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
|
US7858666B2
(en)
|
2007-06-08 |
2010-12-28 |
Mannkind Corporation |
IRE-1α inhibitors
|
PE20090837A1
(es)
*
|
2007-07-02 |
2009-07-24 |
Boehringer Ingelheim Int |
Nuevos compuestos quimicos
|
WO2009003998A2
(en)
*
|
2007-07-02 |
2009-01-08 |
Boehringer Ingelheim International Gmbh |
Antiproliferative compounds based on 5-membered heterocycles
|
ATE499099T1
(de)
|
2007-07-19 |
2011-03-15 |
Esteve Labor Dr |
Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
|
ES2421237T7
(es)
|
2007-08-15 |
2013-09-30 |
Arena Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
|
US20110021538A1
(en)
*
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
BRPI0920608A2
(pt)
|
2008-09-29 |
2019-09-24 |
Boehringer Ingelheim Int |
compostos quimicos
|
PT2364142T
(pt)
|
2008-10-28 |
2018-04-23 |
Arena Pharm Inc |
Composições de um modulador do recetor da serotonina 5-ht2a para o tratamento de distúrbios com ele relacionados
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
KR20110114664A
(ko)
|
2009-01-16 |
2011-10-19 |
메사추세츠 인스티튜트 오브 테크놀로지 |
자폐 스펙트럼 장애의 진단 및 치료
|
DK2477629T3
(en)
*
|
2009-09-17 |
2016-08-22 |
Univ Vanderbilt |
SUBSTITUTED HETEROARYLAMIDANALOGER AS mGluR5 allosteric modulators NEGATIVE AND METHODS OF MAKING AND USE THEREOF
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
EP2552907B1
(en)
|
2010-03-26 |
2014-10-22 |
Boehringer Ingelheim International GmbH |
Pyridyltriazoles
|
EP2552905B1
(en)
|
2010-03-26 |
2016-10-05 |
Boehringer Ingelheim International GmbH |
B-Raf kinase inhibitors
|
US9751847B2
(en)
|
2010-10-14 |
2017-09-05 |
University Of Utah Research Foundation |
Methods and compositions related to neuroactive thiazoline compounds
|
US8710055B2
(en)
|
2010-12-21 |
2014-04-29 |
Boehringer Ingelheim International Gmbh |
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
KR101972619B1
(ko)
*
|
2011-09-29 |
2019-04-25 |
오노 야꾸힝 고교 가부시키가이샤 |
페닐 유도체
|
US9926309B2
(en)
|
2011-10-05 |
2018-03-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
WO2013052845A1
(en)
|
2011-10-05 |
2013-04-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
RU2644769C2
(ru)
|
2013-01-23 |
2018-02-14 |
Астразенека Аб |
Химические соединения
|
EP3071568A1
(en)
|
2013-11-19 |
2016-09-28 |
Vanderbilt University |
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mglur5
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
RU2017145976A
(ru)
|
2015-06-12 |
2019-07-15 |
Аксовант Сайенсиз Гмбх |
Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
|
WO2017007755A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
HUE057041T2
(hu)
|
2015-07-06 |
2022-04-28 |
Alkermes Inc |
Hiszton deacetiláz hetero-halogén gátlói
|
KR20180064373A
(ko)
|
2015-07-15 |
2018-06-14 |
엑소반트 사이언시즈 게엠베하 |
신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ[3,4−d][1,3]オキサジン誘導体、およびbace阻害剤としてのその使用
|
US10300155B2
(en)
|
2015-12-31 |
2019-05-28 |
Washington University |
Alpha-synuclein ligands
|
EP3419980A4
(en)
|
2016-02-26 |
2019-07-03 |
The Board of Trustees of the Leland Stanford Junior University |
INHIBITORS OF PI-KINASE WITH ANTI-INFECTIOUS ACTIVITY
|
MD3570834T2
(ro)
|
2017-01-11 |
2022-04-30 |
Alkermes Inc |
Inhibitori biciclici ai histon deacetilazei
|
WO2019032528A1
(en)
|
2017-08-07 |
2019-02-14 |
Rodin Therapeutics, Inc |
BICYCLIC HISTONE DEACETYLASE INHIBITORS
|
CA3089630A1
(en)
|
2018-01-31 |
2019-08-08 |
Deciphera Pharmaceuticals, Llc |
Combination therapy for the treatment of mastocytosis
|
SG11202007198WA
(en)
|
2018-01-31 |
2020-08-28 |
Deciphera Pharmaceuticals Llc |
Combination therapy for the treatment of gastrointestinal stromal tumors
|
MX2022001863A
(es)
|
2019-08-12 |
2022-05-30 |
Deciphera Pharmaceuticals Llc |
Metodos para tratar los tumores del estroma gastrointestinal.
|
TW202122082A
(zh)
|
2019-08-12 |
2021-06-16 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
DK4084778T3
(da)
|
2019-12-30 |
2023-12-11 |
Deciphera Pharmaceuticals Llc |
Amorfe kinaseinhibitorformuleringer og fremgangsmåder til anvendelse deraf
|
KR20220123058A
(ko)
|
2019-12-30 |
2022-09-05 |
데시페라 파마슈티칼스, 엘엘씨. |
1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
|
MX2024007221A
(es)
*
|
2021-12-15 |
2024-08-27 |
Delix Therapeutics Inc |
Psicoplastogenos sustituidos con fenoxi y benciloxi y sus usos.
|
WO2023114325A1
(en)
*
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Constrained amine psychoplastogens and uses thereof
|
IL313457A
(he)
*
|
2021-12-15 |
2024-08-01 |
Delix Therapeutics Inc |
פירולידין פסיכופלסטוגנים דחוסים ושימושים בהם
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|